Subject: | |
From: | |
Reply To: | |
Date: | Sat, 8 Feb 1997 15:26:49 -0500 |
Content-Type: | text/plain |
Parts/Attachments: |
|
|
D Vandoski wrote:
>
> I have been told that fine tuning your Synthroid levels makes a big
> difference
> in some thyroid patients, but can be difficult for the doctor and the patient
> because it requires cutting pills or alternating pills. Why don't the makers
> of Synthroid make a .005 and .010, which could make it much easier for
> the doctor and patient for fine tuning. Example: If a patient is hypo on
> .125
> and hyper on .150, wouldn't it make it easier if you had 4 to 8 different
> levels to work with? Or does fine tuning really mean much? If these pills
> were available, these would be the dosages you could obtain between .125
> and .150 (.130, .135, .140, .145). And there would be more if you wanted
> to split the .005.
>
> Any help with this question would be greatly appreciated.
>
> Lynne
Because, lynne,
its economics. Not enough people need those doses. They wouldn't make
enought money from it.
The same reason there's not much research on very rare disease. Why find
a cure when only a few people would benefit?
|
|
|